We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAX icon
51
Baxter International
BAX
$14.4B
$58M 0.44%
673,982
+12,908
+2% +$1.12M
VLO icon
52
Valero Energy
VLO
$85.4B
$55.9M 0.42%
950,918
+8,737
+0.9% +$522K
MKTX icon
53
MarketAxess Holdings
MKTX
$5.72B
$54.9M 0.41%
109,521
-4,719
-4% -$2.2M
BAC icon
54
Bank of America
BAC
$441B
$51.8M 0.39%
2,180,098
+200,144
+10% +$4.73M
INTC icon
55
Intel
INTC
$509B
$51M 0.38%
852,395
-30,750
-3% -$1.84M
NKE icon
56
Nike
NKE
$62B
$50M 0.38%
509,839
-25,523
-5% -$2.36M
AMT icon
57
American Tower
AMT
$80.7B
$48.3M 0.36%
186,942
+849
+0.5% +$210K
MSI icon
58
Motorola Solutions
MSI
$78.1B
$43.9M 0.33%
313,137
+59,365
+23% +$8.4M
TGT icon
59
Target
TGT
$67.7B
$39.5M 0.3%
329,349
+13,496
+4% +$1.54M
WSO icon
60
Watsco Inc
WSO
$13.6B
$38.8M 0.29%
218,412
+2,922
+1% +$484K
CINF icon
61
Cincinnati Financial
CINF
$27.2B
$36.8M 0.28%
575,221
-6,028
-1% -$398K
ECL icon
62
Ecolab
ECL
$79.7B
$35.3M 0.27%
177,506
-5,732
-3% -$1.11M
ES icon
63
Eversource Energy
ES
$27.3B
$35M 0.26%
420,146
+9,775
+2% +$809K
D icon
64
Dominion Energy
D
$59.5B
$34.8M 0.26%
428,983
+53,859
+14% +$4.32M
BDX icon
65
Becton Dickinson
BDX
$48.7B
$33.7M 0.25%
144,402
-3,275
-2% -$789K
MKC icon
66
McCormick & Company Non-Voting
MKC
$14.2B
$31.8M 0.24%
354,910
-32,582
-8% -$2.68M
ATO icon
67
Atmos Energy
ATO
$28.9B
$30.6M 0.23%
306,996
+1,504
+0.5% +$152K
RPM icon
68
RPM International
RPM
$15B
$27.8M 0.21%
370,632
-13,079
-3% -$909K
LYB icon
69
LyondellBasell Industries
LYB
$19.3B
$26.2M 0.2%
399,113
+4,131
+1% +$246K
V icon
70
Visa
V
$678B
$24.3M 0.18%
125,702
+75,437
+150% +$13.8M
PFE icon
71
Pfizer
PFE
$152B
$23.9M 0.18%
771,968
-2,351,795
-75% -$79.9M
LHX icon
72
L3Harris
LHX
$53.4B
$22.9M 0.17%
134,845
+20,166
+18% +$3.79M
DLR icon
73
Digital Realty Trust
DLR
$71.7B
$22.8M 0.17%
160,403
+255
+0.2% +$36.1K
XOM icon
74
ExxonMobil
XOM
$632B
$22.2M 0.17%
495,600
-35,316
-7% -$1.58M
WFC icon
75
Wells Fargo
WFC
$264B
$20.6M 0.16%
805,400
-285,334
-26% -$7.81M

Similar funds

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.